shortagewatch

Home / Dabigatran Etexilate / Norway

NO ATC B01AE07 · updated 2 Nov 2026

Dabigatran Etexilate shortage in Norway

Is there a Dabigatran Etexilate shortage in Norway?

Yes. As of 2 Nov 2026, 6 Dabigatran Etexilate products are reported short in Norway, the first since 1 Oct 2026. The company estimate for the return is 1 Dec 2026. Main reason: commercial decision or withdrawal.

Also short in Canada, Germany, Italy, Spain, Austria, Belgium, Czechia, Sweden, Australia. All countries.

Affected products in Norway

CountryProductCompanySinceExpected backReason
NOPradaxa 110 mg granulat, drasjert, 60 x 1 stk doseposeBoehringer Ingelheim International GmbH1 Oct 20261 Dec 2026Commercial decision or withdrawal
Planlagt utfasing/avregistrering
NOPradaxa 150 mg granulat, drasjert, 60x1 stk doseposeBoehringer Ingelheim International Gmbh1 Oct 20261 Dec 2026Commercial decision or withdrawal
Planlagt utfasing/avregistrering
NOPradaxa 20 mg granulat, drasjert, 60 x 1 stk doseposeBoehringer Ingelheim International GmbH1 Oct 20261 Dec 2026Commercial decision or withdrawal
Planlagt utfasing/avregistrering
NOPradaxa 30 mg granulat, drasjert, 60 x 1 stk doseposeBoehringer Ingelheim International GmbH1 Oct 20261 Dec 2026Commercial decision or withdrawal
Planlagt utfasing/avregistrering
NOPradaxa 40 mg granulat, drasjert, 60 x 1 stk doseposeBoehringer Ingelheim International GmbH1 Oct 20261 Dec 2026Commercial decision or withdrawal
Planlagt utfasing/avregistrering
NOPradaxa 50 mg granulat, drasjert, 60 x 1 stk doseposeBoehringer Ingelheim International GmbH1 Oct 20261 Dec 2026Commercial decision or withdrawal
Planlagt utfasing/avregistrering

Source

DMP (Norwegian Medical Products Agency). Official list. Ongoing and announced shortages reported by companies; one row per pack (varenummer).